TrialDiabetes, obesity & metabolism2017

Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial.

Tim Heise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.